Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo. | Clin Transl Med | 2024 | 38685487 | PubTator, text mining | PubMed |
| Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy. | Int J Mol Sci | 2024 | 38612592 | PubTator, text mining | PubMed |
| IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomas. | Nat Rev Clin Oncol | 2024 | 38514882 | PubTator, text mining | PubMed |
| Author Correction: Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. | Nat Med | 2024 | 38514871 | PubTator, text mining | PubMed |
| Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results. | Nat Med | 2024 | 38480922 | PubTator, text mining | PubMed |
| Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. Cancers 2023, 15, 2772. | Cancers (Basel) | 2024 | 38473435 | PubTator, text mining | PubMed |
| German cockroach extract prevents IL-13-induced CCL26 expression in airway epithelial cells through IL-13 degradation. | FASEB J | 2024 | 38466220 | PubTator, text mining | PubMed |
| Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. | Nat Med | 2024 | 38454126 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment. | J Hepatocell Carcinoma | 2024 | 38410699 | PubTator, text mining | PubMed |
| Quantifying Landscape-Flux via Single-Cell Transcriptomics Uncovers the Underlying Mechanism of Cell Cycle. | Adv Sci (Weinh) | 2024 | 38353329 | PubTator, text mining | PubMed |
| Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma. | Nanoscale | 2024 | 38321967 | PubTator, text mining | PubMed |
| Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma. | NPJ Precis Oncol | 2024 | 38302615 | PubTator, text mining | PubMed |
| Tissue markers may predict treatment response to antitumor necrosis factor-α agents in children with Crohn's disease. | J Pediatr Gastroenterol Nutr | 2024 | 38299301 | PubTator, text mining | PubMed |
| When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report. | J Med Case Rep | 2024 | 38291489 | PubTator, text mining | PubMed |
| IL13Rα2 as a crucial receptor for Chi3l1 in osteoclast differentiation and bone resorption through the MAPK/AKT pathway. | Cell Commun Signal | 2024 | 38291404 | PubTator, text mining | PubMed |
| Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis. | Clin Transl Allergy | 2024 | 38282195 | PubTator, text mining | PubMed |
| CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review). | Mol Med Rep | 2024 | 38275119 | PubTator, text mining | PubMed |
| Prognosis and immunotherapy response prediction based on M2 macrophage-related genes in colon cancer. | J Cancer Res Clin Oncol | 2024 | 38270646 | PubTator, text mining | PubMed |
| A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype. | J Exp Clin Cancer Res | 2024 | 38263178 | PubTator, text mining | PubMed |
| Experimental Tumor Induction and Evaluation of Its Treatment in the Chicken Embryo Chorioallantoic Membrane Model: A Systematic Review. | Int J Mol Sci | 2024 | 38255911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=9